Vaccinex, Inc. (VCNX) Operating income 2017–2024
Vaccinex, Inc. (VCNX) annual operating income history from SEC filings — each fiscal year as reported.
-$18.7MFY2024 · since FY2017: -$21.1M → -$18.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$18.7M | +18.1% |
| FY2023 | -$22.9M | -15.0% |
| FY2022 | -$19.9M | +11.5% |
| FY2021 | -$22.5M | +20.6% |
| FY2020 | -$28.3M | +11.5% |
| FY2019 | -$32.0M | -17.4% |
| FY2018 | -$27.3M | -29.3% |
| FY2017 | -$21.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VCNX financial trends
VCNX RevenueVCNX Net incomeVCNX Net marginVCNX Gross profitVCNX Gross marginVCNX Operating marginVCNX Operating cash flowVCNX Free cash flowVCNX Capital expendituresVCNX Return on equityVCNX Stock buybacksVCNX Dividends paidVCNX Total assetsVCNX Total liabilitiesVCNX Shareholders’ equityVCNX overview →